Ductal carcinoma in situ of the breast: A surgical perspective

International Journal of Surgical Oncology

Volumn 2012, Issue , 2012, Pages

  Badruddoja, Mohammed ^a  

^a Rehabilitation Associate of Northern Illinois   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867831825     PISSN: 20901402     EISSN: 20901410     Source Type: Journal    
DOI: 10.1155/2012/761364     Document Type: Article

References (127)

1. Shampo M. A., Kyle R. A., Pioneers of mammographyWarren and Egan. Mayo Clinic Proceedings 1997 72 1, article 32 2-s2.0-0030635743
2. Rosner D., Bedwani R. N., Vana J., Noninvasive breast carcinoma. Results of a national survey by the American College of Surgeons. Annals of Surgery 1980 192 3 139 147 2-s2.0-0018971753
3. Brinton L. A., Sherman M. E., Carreon J. D., Anderson W. F., Recent trends in breast cancer among younger women in the United States. Journal of the National Cancer Institute 2008 100 22 1643 1648 2-s2.0-56749104678 10.1093/jnci/djn344
4. Ernster V. L., Ballard-Barbash R., Barlow W. E., Zheng Y., Weaver D. L., Cutter G., Yankaskas B. C., Rosenberg R., Carney P. A., Kerlikowske K., Taplin S. H., Urban N., Geller B. M., Detection of ductal carcinoma in situ in women undergoing screening mammography. Journal of the National Cancer Institute 2002 94 20 1546 1554 2-s2.0-0037120975
5. May D. S., Lee N. C., Richardson L. C., Giustozzi A. G., Bobo J. K., Mammography and breast cancer detection by race and Hispanic ethnicity: results from a national program (United States). Cancer Causes and Control 2000 11 8 697 705 2-s2.0-0033783648 10.1023/A:1008900220924
6. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009. CA: A Cancer Journal for Clinicians 2009 59 4 225 249 2-s2.0-67650874081 10.3322/caac.20006
7. Li C. I., Daling J. R., Malone K. E., Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiology Biomarkers and Prevention 2005 14 4 1008 1011 2-s2.0-16444373495 10.1158/1055-9965.EPI-04-0849
8. Ernster V. L., Barclay J., Kerlikowske K., Grady D., Henderson I. C., Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996 275 12 913 918 2-s2.0-0029995273 10.1001/jama.275.12.913
9. Horner M., Rice L., Krapcho M., SEER Cancer Statistics Review, 19752006 2009 Bethesda, Md, USA National Cancer Institute
10. Virnig B. A., Tuttle T. M., Shamliyan T., Kane R. L., Ductal carcinoma in Situ of the breast: a systematic review of incidence, treatment, and outcomes. Journal of the National Cancer Institute 2010 102 3 170 178 2-s2.0-76349106646 10.1093/jnci/djp482
11. Tabar L., Fagerberg G., Chen H.-H., Duffy S. W., Smart C. R., Gad A., Smith R. A., Efficacy of breast cancer screening by age: new results from the Swedish two-county trial. Cancer 1995 75 10 2507 2517 2-s2.0-0029005094 10.1002/1097-0142(19950515)75:102507::AID-CNCR2820751017>3.0.CO;2-H
12. Tabár L., Vitak B., Chen H. H., Duffy S. W., Yen M. F., Chiang C. F., Krusemo U. B., Tot T., Smith R. A., The Swedish two-county trial twenty years later: updated mortality results and new insights from long-term follow-up. Radiologic Clinics of North America 2000 38 4 625 651 2-s2.0-0033889950
13. Coburn N. G., Chung M. A., Fulton J., Cady B., Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened population. Cancer Control 2004 11 4 222 230 2-s2.0-3242802132
14. Fracheboud J., Otto S. J., Van Dijck J. A. M. M., Broeders M. J. M., Verbeek A. L. M., De Koning H. J., Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. British Journal of Cancer 2004 91 5 861 867 2-s2.0-4644353787 10.1038/sj.bjc.6602075
15. Anderson W. F., Chu K. C., Devesa S. S., Distinct incidence patterns among in situ and invasive breast carcinomas, with possible etiologic implications. Breast Cancer Research and Treatment 2004 88 2 149 159 2-s2.0-9644283041 10.1007/s10549-004-1483-9
16. Chen C. Y., Sun L. M., Anderson B. O., Paget disease of the breast: changing patterns of incidence, clinical presentation, and treatment in the U.S. Cancer 2006 107 7 1448 1458 2-s2.0-33749593105 10.1002/cncr.22137
17. Weaver D. L., Vacek P. M., Skelly J. M., Geller B. M., Predicting biopsy outcome after mammography: what is the likelihood the patient has invasive or in situ breast cancer? Annals of Surgical Oncology 2005 12 8 660 673 2-s2.0-23744499629 10.1245/ASO.2005.09.008
18. Tavassoli F., Ductal intraepithelial neoplasia of the breast. Virchows Archiv 2001 438 3 221 227 2-s2.0-0035079249 10.1007/s004280100394
19. Kricker A., Goumas C., Armstrong B., Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology. British Journal of Cancer 2004 90 7 1382 1385 2-s2.0-2342483089 10.1038/sj.bjc.6601677
20. Claus E. B., Stowe M., Carter D., Breast carcinoma in situ: risk factors and screening patterns. Journal of the National Cancer Institute 2001 93 23 1811 1817 2-s2.0-0035814452
21. Reeves G. K., Beral V., Green J., Gathani T., Bull D., Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. The Lancet Oncology 2006 7 11 910 918 2-s2.0-33750358229 10.1016/S1470-2045(06)70911-1
22. Gapstur S. M., Morrow M., Sellers T. A., Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. JAMA 1999 281 22 2091 2141 2-s2.0-0344517349 10.1001/jama.281.22. 2091
23. Claus E. B., Stowe M., Carter D., Oral contraceptives and the risk of ductal breast carcinoma in situ. Breast Cancer Research and Treatment 2003 81 2 129 136 2-s2.0-0141639766 10.1023/A:1025728524310
24. Kerlikowske K., Barclay J., Grady D., Sickles E. A., Ernster V., Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. Journal of the National Cancer Institute 1997 89 1 77 82 2-s2.0-0030636730
25. Wohlfahrt J., Rank F., Kroman N., Melbye M., A comparison of reproductive risk factors for CIS lesions and invasive breast cancer. International Journal of Cancer 2004 108 5 750 753 2-s2.0-0346655245 10.1002/ijc.11588
26. National and Medical Research Council, Hormone Replacement Therapy: A Summary of the Evidence for General Practitioners and oOther Health Professionals 2005 Canberra, Australia National Health and Medical Council
27. Rossouw J. E., Anderson G. L., Prentice R. L., LaCroix A. Z., Kooperberg C., Stefanick M. L., Jackson R. D., Beresford S. A. A., Howard B. V., Johnson K. C., Kotchen J. M., Ockene J., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002 288 3 321 333 2-s2.0-0037125379
28. Anderson G. L., Chlebowski R. T., Rossouw J. E., Rodabough R. J., McTiernan A., Margolis K. L., Aggerwal A., David Curb J., Hendrix S. L., Allan Hubbell F., Khandekar J., Lane D. S., Lasser N., Lopez A. M., Potter J., Ritenbaugh C., Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 2006 55 2 103 115 2-s2.0-33748119290 10.1016/j.maturitas.2006.05.004
29. Stefanick M. L., Anderson G. L., Margolis K. L., Hendrix S. L., Rodabough R. J., Paskett E. D., Lane D. S., Hubbell F. A., Assaf A. R., Sarto G. E., Schenken R. S., Yasmeen S., Lessin L., Chlebowski R. T., Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006 295 14 1647 1657 2-s2.0-33645750336 10.1001/jama.295.14.1647
30. Chen W. Y., Manson J. E., Hankinson S. E., Rosner B., Holmes M. D., Willett W. C., Colditz G. A., Unopposed estrogen therapy and the risk of invasive breast cancer. Archives of Internal Medicine 2006 166 9 1027 1032 2-s2.0-33646396452 10.1049/el:20061631
31. Tamimi R. M., Hankinson S. E., Chen W. Y., Rosner B., Colditz G. A., Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Archives of Internal Medicine 2006 166 14 1483 1489 2-s2.0-33746387475 10.1001/archinte.166.14.1483
32. Cummings S. R., Ettinger B., Delmas P. D., Kenemans P., Stathopoulos V., Verweij P., Mol-Arts M., Kloosterboer L., Mosca L., Christiansen C., Bilezikian J., Kerzberg E. M., Johnson S., Zanchetta J., Grobbee D. E., Seifert W., Eastell R., The effects of tibolone in older postmenopausal women. The New England Journal of Medicine 2008 359 7 697 708 2-s2.0-49449084993 10.1056/NEJMoa0800743
33. Australian Bureau of Statistics, National Health Survey, Australia (2004-2005) 2006 Canberra, Australia Australian Bureau of Statistics
34. Trentham-Dietz A., Newcomb P. A., Storer B. E., Remington P. L., Risk factors for carcinoma in situ of the breast. Cancer Epidemiology Biomarkers and Prevention 2000 9 7 697 703 2-s2.0-0033927857
35. Friedenreich C. M., Woolcott C. G., McTiernan A., Ballard-Barbash R., Brant R. F., Stanczyk F. Z., Terry T., Boyd N. F., Yaffe M. J., Irwin M. L., Jones C. A., Yasui Y., Campbell K. L., McNeely M. L., Karvinen K. H., Wang Q., Courneya K. S., Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. Journal of Clinical Oncology 2010 28 9 1458 1466 2-s2.0-77951913790 10.1200/JCO.2009.24.9557
36. Boyd N. F., Guo H., Martin L. J., Sun L., Stone J., Fishell E., Jong R. A., Hislop G., Chiarelli A., Minkin S., Yaffe M. J., Mammographic density and the risk and detection of breast cancer. The New England Journal of Medicine 2007 356 3 227 236 2-s2.0-33846407655 10.1056/NEJMoa062790
37. Lin J., Cook N. R., Albert C., Zaharris E., Gaziano J. M., Van Denburgh M., Buring J. E., Manson J. E., Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. Journal of the National Cancer Institute 2009 101 1 14 23 2-s2.0-58549094920 10.1093/jnci/djn438
38. Johnson T. W., Anderson K. E., Lazovich D., Folsom A. R., Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiology Biomarkers and Prevention 2002 11 12 1586 1591 2-s2.0-0036911961
39. Holmes M. D., Chen W. Y., Li L., Hertzmark E., Spiegelman D., Hankinson S. E., Aspirin intake and survival after breast cancer. Journal of Clinical Oncology 2010 28 9 1467 1472 2-s2.0-77951921896 10.1200/JCO.2009.22.7918
40. Algra A. M., Roth P. M., Effects of aspirin on long-term cancer incidence and metastasis: a systemic comparison of evidence from observational studies versus randomized trial. The Lancet Oncology 2012 13 5 518 527
41. Nair N. S., Pandey N., Vanmali P.V., Journal of Clinical Oncology 2001 29 27 146
42. Ruggiero R., Procaccini E., Sanguinetti A., Cremone C., Gili S., Docimo G., Docimo L., Sparavigna L., Gubitosi A., Parmeggiani D., Avenia N., Ductal carcinoma in situ of the breast: our experience. Il Giornale di Chirurgia 2009 30 3 121 124 2-s2.0-67650492941
43. Nelson H. D., Tyne K., Naik A., Screening for breast cancer: US preventive task force recommendation statement. Annals of International Medicine 2009 151 10 716 726
44. Hendrick R. E., Pisano E. D., Averbukh A., Moran C., Berns E. A., Yaffe M. J., Herman B., Acharyya S., Gatsonis C., Comparison of acquisition parameters and breast dose in digital mammography and screen-film mammography in the American College of Radiology imaging network digital mammographic imaging screening trial. American Journal of Roentgenology 2010 194 2 362 369 2-s2.0-76149099559 10.2214/AJR.08.2114
45. Kerlikowske K., Hubbard R. A., Miglioretti D. L., Geller B. M., Yankaskas B. C., Lehman C. D., Taplin S. H., Sickles E. A., Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Annals of Internal Medicine 2011 155 8 493 502 2-s2.0-80054717098
46. Riedl C. C., Ponhold L., Flöry D., Weber M., Kroiss R., Wagner T., Fuchsjäger M., Helbich T. H., Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clinical Cancer Research 2007 13 20 6144 6152 2-s2.0-35949002447 10.1158/1078-0432.CCR- 07-1270
47. Kuhl C. K., Schrading S., Bieling H. B., Wardelmann E., Leutner C. C., Koenig R., Kuhn W., Schild H. H., MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. The Lancet 2007 370 9586 485 492 2-s2.0-34547655642 10.1016/S0140-6736(07)61232-X
48. Hwang E. S., Kinkel K., Esserman L. J., Lu Y., Weidner N., Hylton N. M., Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Annals of Surgical Oncology 2003 10 4 381 388 2-s2.0-0043163407 10.1245/ASO.2003.03.085
49. Menell J. H., Morris E. A., Dershaw D. D., Abramson A. F., Brogi E., Liberman L., Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast Journal 2005 11 6 382 390 2-s2.0-28544453295 10.1111/j.1075-122X.2005.00121.x
50. Santamaría G., Velasco M., Farrús B., Zanón G., Fernández P. L., Preoperative MRI of pure intraductal breast carcinoma-A valuable adjunct to mammography in assessing cancer extent. Breast 2008 17 2 186 194 2-s2.0-41549102901 10.1016/j.breast.2007.09.005
51. Hollingsworth A. B., Stough R. G., Preoperative breast MRI for locoregional staging. The Journal of the Oklahoma State Medical Association 2006 99 10 505 515 2-s2.0-39049183844
52. Hollingsworth A. B., Stough R. G., O'Dell C. A., Brekke C. E., Breast magnetic resonance imaging for preoperative locoregional staging. American Journal of Surgery 2008 196 3 389 397 2-s2.0-49349099705 10.1016/j.amjsurg.2007. 10.009
53. Uematsu T., Yuen S., Kasami M., Uchida Y., Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer. Breast Cancer Research and Treatment 2008 112 3 461 474 2-s2.0-56549088142 10.1007/s10549-008-9890-y
54. Lehman C. D., Gatsonis C., Kuhl C. K., Hendrick R. E., Pisano E. D., Hanna L., Peacock S., Smazal S. F., Maki D. D., Julian T. B., DePeri E. R., Bluemke D. A., Schnall M. D., MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. The New England Journal of Medicine 2007 356 13 1295 1303 2-s2.0-34047099266 10.1056/NEJMoa065447
55. Gwak Y. J., Kim H. J., Kwak J. Y., Lee S. K., Shin K. M., Lee H. J., Kim G. C., Jang Y. J., Han M. H., Park J. Y., Jung J. H., Ultrasonographic detection and characterization of asymptomatic ductal carcinoma in situ with histopathologic correlation. Acta Radiologica 2011 52 4 364 371 2-s2.0-79960070513 10.1258/ar.2011.100391
56. Moon W. K., Myung J. S., Lee Y. J., Park I. A., Noh D. Y., Im J. G., US of ductal carcinoma in situ. Radiographics 2002 22 2 269 281 2-s2.0-0036517454
57. Badruddoja M., Yang J. H., Size of breast cancer tumor after core-needle biopsy and fine-needle aspiration does not affect patient treatment plan. Archives of Surgery 2005 140 10 1008 1009 2-s2.0-26844436567 10.1001/archsurg.140.10.1008
58. Badruddoja M., Image-guided treatment of breast cancer. Journal of the American College of Surgeons 2010 210 3 372 374 2-s2.0-77249159874 10.1016/j.jamcollsurg.2009.12.011
59. Badruddoja M., Routine preoperative MRI for breast carcinoma. Journal of the American College of Surgeons 2010 210 2 253 255 2-s2.0-74749101674 10.1016/j.jamcollsurg.2009.10.014
60. Lee C. H., Carter D., Philpotts L. E., Couce M. E., Horvath L. J., Lange R. C., Tocino I., Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology 2000 217 2 466 470 2-s2.0-0033744928
61. Golub R. M., Bennett C. L., Stinson T., Venta L., Morrow M., Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. Journal of Clinical Oncology 2004 22 12 2430 2437 2-s2.0-2942729845 10.1200/JCO.2004.06.154
62. Brennan M. E., Turner R. M., Ciatto S., Marinovich M. L., French J. R., Macaskill P., Houssami N., Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 2011 260 1 119 128 2-s2.0-79959560096 10.1148/radiol.11102368
63. Rosen P. P., Oberman H., Tumors of Mammary Gland 1993 Washington, DC, USA Armed Forces Institute of Pathology
64. Silverstein M. J., Poller D. N., Waisman J. R., Colburn W. J., Barth A., Gierson E. D., Lewinsky B., Gamagami P., Slamon D. J., Prognostic classification of breast ductal carcinoma-in-situ. The Lancet 1995 345 8958 1154 1157 2-s2.0-0029021632
65. Sloane J. P., Amendoeira I., Apostolikas N., Bellocq J. P., Bianchi S., Boecker W., Bussolati G., Coleman D., Connolly C. E., Dervan P., Eusebi V., De Miguel C., Drijkoningen M., Elston C. W., Faverley D., Gad A., Jacquemier J., Lacerda M., Martinez-Penuela J., Munt C., Peterse J. L., Rank F., Sylvan M., Tsakraklides V., Zafrani B., Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. Human Pathology 1998 29 10 1056 1062 2-s2.0-13144283619
66. The Census Conference Committee, Consensus conference of the classification of ductal carcinoma in situ. Cancer 1997 80 9 1798 1802
67. Allred D. C., Ductal carcinoma in situ: terminology, classification, and natural history. Journal of the National Cancer Institute. Monographs 2010 2010 41 134 138 2-s2.0-79952198032
68. Cardenosa G., Clinical Breast Imaging, a Patient Focused Teaching File 2006 Philadelphia, Pa, USA Lippincott Williams & Wilkins
69. Chapman J. A., Miller N. A., Lickley H. L., Qian J., Christens-Barry W. A., Fu Y., Yuan Y., Axelrod D. E., Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment. BMC Cancer 2007 7, article 174 2-s2.0-36049017900 10.1186/1471-2407-7-174
70. Rosai J., Borderline epithelial lesions of the breast. American Journal of Surgical Pathology 1991 15 3 209 221 2-s2.0-0025817521
71. Costa A., Zanini V., Precancerous lesions of the breast. Nature Clinical Practice Oncology 2008 5 12 700 704 2-s2.0-57049102844 10.1038/ncponc1239
72. Guerrieri-Gonzaga A., Botteri E., Rotmensz N., Bassi F., Lntra M., Serrano D., Renne G., Luini A., Cazzaniga M., Goldhirsch A., Colleoni M., Viale G., Ivaldi G., Bagnardi V., Lazzeroni M., Decensi A., Veronesi U., Bonanni B., Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years. Oncologist 2009 14 3 201 212 2-s2.0-63849240522 10.1634/theoncologist.2008-0203
73. Guidi A. J., Fischer L., Harris J. R., Schnitt S. J., Microvessel density and distribution in ductal carcinoma in situ of the breast. Journal of the National Cancer Institute 1994 86 8 614 619 2-s2.0-0028203848
74. Evans A. J., Pinder S. E., Ellis I. O., Sibbering D. M., Elston C. W., Poller D. N., Wilson A. R. M., Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Clinical Radiology 1994 49 8 559 562 2-s2.0-0028095003
75. Burstein H. J., Polyak K., Wong J. S., Lester S. C., Kaelin C. M., Ductal carcinoma in situ of the breast. The New England Journal of Medicine 2004 350 14 1430 1441 2-s2.0-1842483408 10.1056/NEJMra031301
76. Allred D. C., Clark G. M., Molina R., Tandon A. K., Schnitt S. J., Gilchrist K. W., Osborne C. K., Tormey D. C., McGuire W. L., Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Human Pathology 1992 23 9 974 979 2-s2.0-0026793986 10.1016/0046-8177(92)90257-4
77. Rudas M., Neumayer R., Gnant M. F. X., Mittelböck M., Jakesz R., Reiner A., p53 Protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. European Journal of Cancer Part A 1997 33 1 39 44 2-s2.0-0031021137 10.1016/S0959- 8049(96)00368-1
78. Dabbs D. J., Chivukula M., Carter G., Bhargava R., Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile. Modern Pathology 2006 19 11 1506 1511 2-s2.0-33750321934 10.1038/modpathol.3800678
79. Kasami M., Gobbi H., Dupont W. D., Simpson J. F., Page D. L., Vnencak-Jones C. L., Androgen receptor CAG repeat lengths in ductal carcinoma in situ of breast, longest in apocrine variety. Breast 2000 9 1 23 27 2-s2.0-0034118822 10.1054/brst.1999.0070
80. Acs G., Lawton T. J., Rebbeck T. R., LiVolsi V. A., Zhang P. J., Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implication. American Journal of Clinical Pathology 2001 115 1 85 98 2-s2.0-0035229053 10.1309/FDHX-L92R-BATQ-2GE0
81. Wiechmann L., Kuerer H. M., The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 2008 112 10 2130 2142 2-s2.0-43049117148 10.1002/cncr.23430
82. Kerlikowske K., Molinari A. M., Gauthier M. L., Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. Journal of the National Cancer Institute 2010 102 9 627 637
83. INK4a expression and breast cancer risk in women with atypical hyperplasia. Cancer Prevention Research 2011 4 12 1953 1960 2-s2.0-83055162322 10.1158/1940-6207.CAPR-11-0282
84. Adler E. H., Sunkara J., Patchefsky A. S., Predictor of disease progression in ductal carcinoma in situ of the breast and vascular pattern. Human Pathology 2012 43 4 550 556
85. Ernster V. L., Barclay J., Kerlikowske K., Wilkie H., Ballard-Barbash R., Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Archives of Internal Medicine 2000 160 7 953 958 2-s2.0-0034630285
86. Arnesson L. G., Smeds S., Fagerberg G., Grontoft O., Follow-up of two treatment modalities for ductal cancer in situ of the breast. British Journal of Surgery 1989 76 7 672 675 2-s2.0-0024340160
87. Fisher B., Bauer M., Margolese R., Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. The New England Journal of Medicine 1985 312 11 665 673 2-s2.0-0021923669
88. Winchester D. J., Menck H. R., Winchester D. P., National treatment trends for ductal carcinoma in situ of the breast. Archives of Surgery 1997 132 6 660 665 2-s2.0-0030956084
89. Fisher E. R., Sass R., Fisher B., Pathologic findings from the National Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DICS). Cancer 1986 57 2 197 208 2-s2.0-0022643721
90. Recht A., Danoff B. S., Solin L. J., Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. Journal of Clinical Oncology 1985 3 10 1329 1343 2-s2.0-0022137280
91. Fisher B., Costantino J., Redmond C., Fisher E., Margolese R., Dimitrov N., Wolmark N., Wickerham D. L., Deutsch M., Ore L., Mamounas E., Poller W., Kavanah M., Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. The New England Journal of Medicine 1993 328 22 1581 1586 2-s2.0-0027241810 10.1056/NEJM199306033282201
92. Julien J. P., Bijker N., Fentiman I. S., Peterse J. L., Delledonne V., Rouanet P., Avril A., Sylvester R., Mignolet F., Bartelink H., Van Dongen J. A., Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. The Lancet 2000 355 9203 528 533 2-s2.0-0034639637
93. Houghton J., Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. The Lancet 2003 362 9378 95 102 2-s2.0-0038304773 10.1016/S0140-6736(03)13859-7
94. Smith B. D., Haffty B. G., Buchholz T. A., Smith G. L., Galusha D. H., Bekelman J. E., Gross C. P., Effectiveness of radiation therapy in older women with ductal carcinoma in situ. Journal of the National Cancer Institute 2006 98 18 1302 1310 2-s2.0-33749002531 10.1093/jnci/djj359
95. Vargas C., Kestin L., Go N., Krauss D., Chen P., Goldstein N., Martinez A., Vicini F. A., Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. International Journal of Radiation Oncology Biology Physics 2005 63 5 1514 1521 2-s2.0-27744433970 10.1016/j.ijrobp.2005.04.045
96. Chuwa E. W. L., Tan V. H. S., Tan P. H., Yong W. S., Ho G. H., Wong C. Y., Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors. ANZ Journal of Surgery 2008 78 1-2 42 48 2-s2.0-38049123498 10.1111/j.1445-2197.2007.04354.x
97. Wärnberg F., Bergh J., Zack M., Holmberg L., Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden. Cancer Epidemiology Biomarkers and Prevention 2001 10 5 495 499 2-s2.0-0034927322
98. Joslyn S. A., Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. Breast Journal 2006 12 1 20 27 2-s2.0-33644889095 10.1111/j.1075-122X.2006.00182.x
99. Revesz E., Khan S. A., What are the safe margins of resection for invasive and in situ breast cancer. Oncology 2011 25 10 1 5
100. Blair S. L., Thompson K., Rococco J., Malcarne V., Beitsch P. D., Ollila D. W., Attuning negative margins in breast-conversion operation: is there a consensus among breast surgeons. Journal of the American College of Surgeons 2009 209 5 608 613 2-s2.0-70350130594 10.1016/j.jamcollsurg.2009.07.026
101. Jiveliouk I., Corn B., Inbar M., Merimsky O., Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy. Oncology 2008 76 1 30 35 2-s2.0-56449097048 10.1159/000178162
102. Kayani N., Bhurgri Y., Ductal carcinoma in situ (DCIS) in Karachi. Journal of the Pakistan Medical Association 2005 55 5 199 202 2-s2.0-22344451176
103. Hughes L. L., Wang M., Page D. L., Gray R., Solin L. J., Davidson N. E., Lowen M. A., Ingle J. N., Recht A., Wood W. C., Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology 2009 27 32 5319 5324 2-s2.0-73949085809 10.1200/JCO.2009.21.8560
104. Benitez P. R., Streeter O., Vicini F., Mehta V., Quiet C., Kuske R., Hayes M. K., Arthur D., Kuerer H., Freedman G., Keisch M., DiPetrillo T., Khan D., Hudes R., Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. American Journal of Surgery 2006 192 4 427 433 2-s2.0-33748424375 10.1016/j.amjsurg.2006.06.013
105. Trombetta M., Julian T. B., Werts D. E., McWilliams W., Kim Y., Miften M., Parda D., Long-term Cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast. American Journal of Clinical Oncology 2009 32 3 314 318 2-s2.0-67749102253 10.1097/COC. 0b013e31818af0b9
106. American Association of Cancer Research, Brachytherapy was associated with two-fold increase risk for mastectomy and complications. American Association of Cancer Research 2011
107. Liberman L., Morris E. A., Dershaw D. D., Abramson A. F., Tan L. K., MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. American Journal of Roentgenology 2003 180 4 901 910 2-s2.0-0037378672
108. Badruddoja M., Micrometastasis and axillary dissection in breast cancer. Archives of Surgery 2010 145 10 1022 1023 2-s2.0-77958565586 10.1001/archsurg.2010.214
109. Claus E. B., Petruzella S., Matloff E., Carter D., Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. JAMA 2005 293 8 964 969 2-s2.0-13944260510 10.1001/jama.293.8.964
110. Hartmann L. C., Sellers T. A., Schaid D. J., Frank T. S., Soderberg C. L., Sitta D. L., Frost M. H., Grant C. S., Donohue J. H., Woods J. E., McDonnell S. K., Vockley C. W., Deffenbaugh A., Couch F. J., Jenkins R. B., Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Journal of the National Cancer Institute 2001 93 21 1633 1637 2-s2.0-0035824069
111. Metcalf K. A., Ghadirian P., Rosen B., Variation in rates of uptake of preventive options in Canadian women carrying the BRCA 1 or BRCA 2 genetic mutation. Open Medicine 2007 1 2 e92 e98
112. Allred D. C., Bryant J., Land S., Estrogen receptor expression as a predictive marker of effectiveness of tamoxifen in the treatment of DCIS: findings from NSABP B-24. Breast Cancer Research and Treatment 2002 76 supplement 1, article S36
113. Bijker N., Meijnen P., Peterse J. L., Bogaerts J., Van Hoorebeeck I., Julien J. P., Gennaro M., Rouanet P., Avril A., Fentiman I. S., Bartelink H., Rutgers E. J. T., Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of european organisation for research and treatment of cancer randomized phase III trial 10853A study by the EORTC breast cancer cooperative group and EORTC radiotherapy group. Journal of Clinical Oncology 2006 24 21 3381 3387 2-s2.0-33746811910 10.1200/JCO.2006.06. 1366
114. Cuzick J., Forbes J. F., Sestak I., Cawthorn S., Hamed H., Holli K., Howell A., Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial. Journal of the National Cancer Institute 2007 99 4 272 282 2-s2.0-33847793068 10.1093/jnci/djk049
115. Warren J. L., Weaver D. L., Bocklage T., Key C. R., Platz C. E., Cronin K. A., Ballard-Barbash R., Willey S. C., Harlan L. C., The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population-based analysis. Cancer 2005 104 9 1840 1848 2-s2.0-27244448734 10.1002/cncr.21406
116. Cauley J. A., Norton L., Lippmann M. E., Continued breast risk reduction in postmenopausal women with raloxefine: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Research and Treatment 2001 65 2 125 134
117. Viring B. A., Samliyan T., Tuttle T. M, Diagnosis and management of ductal carcinoma in situ (DCIS). Evidence Report/Technology Assessment 2009 09-E018 AHRQ
118. Goss P. E., Strasser-Weippl K., Brown M., Santen R., Ingle J., Bissell M., Prevention strategies with aromatase inhibitors. Clinical Cancer Research 2004 10 1, part 2 372S 379S 2-s2.0-1642527865 10.1158/1078-0432.CCR-031210
119. Chen L., Mayer J. A., Krisko T. I., Speers C. W., Wang T., Hilsenbeck S. G., Brown P. H., Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Cancer Research 2009 69 23 8853 8861 2-s2.0-71549116718 10.1158/0008-5472.CAN-09-1636
120. Li Y., Zhang Y., Hill J., Shen Q., Kim H. T., Xu X., Hilsenbeck S. G., Bissonnette R. P., Lamph W. W., Brown P. H., The rexinoid LG100268 prevents the development of preinvasive and invasive estrogen receptor-negative tumors in MMTV-erbB2 mice. Clinical Cancer Research 2007 13 20 6224 6231 2-s2.0-35949000084 10.1158/1078-0432.CCR-06-2681
121. Howe L. R., Rexinoids and breast cancer prevention. Clinical Cancer Research 2007 13 20 5983 5987 2-s2.0-35948985946 10.1158/1078-0432.CCR-07-1065
122. Crowe D. L., Chandraratna R. A., A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Breast Cancer Research 2004 6 5 R546 R555 2-s2.0-4644363465
123. Tada K., Ogiya A., Kimura K., Morizono H., Iijima K., Miyagi Y., Nishimura S., Makita M., Horii R., Akiyama F., Iwase T., Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer. World Journal of Surgical Oncology 2010 8, article 6 2-s2.0-77649328721 10.1186/1477-7819-8-6
124. Intra M., Rotmensz N., Veronesi P., Colleoni M., Iodice S., Paganelli G., Viale G., Veronesi U., Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Annals of Surgery 2008 247 2 315 319 2-s2.0-38549137769 10.1097/SLA.0b013e31815b446b
125. Julian T. B., Land S. R., Fourchotte V., Haile S. R., Fisher E. R., Mamounas E. P., Costantino J. P., Wolmark N., Is sentinel node biopsy necessary in conservatively treated DCIS? Annals of Surgical Oncology 2007 14 8 2202 2208 2-s2.0-34547449160 10.1245/s10434-007-9353-4
126. Katz S. J., Lantz P. M., Janz N. K., Fagerlin A., Schwanz R., Liu L., Deapen D., Salem B., Lakhani I., Morrow M., Patient involvement in surgery treatment decisions for breast cancer. Journal of Clinical Oncology 2005 23 24 5526 5533 2-s2.0-24944436757 10.1200/JCO.2005.06.217
127. Katz S. J., Lantz P. M., Janz N. K., Fagerlin A., Schwartz K., Liu L., Deapen D., Salem B., Lakhani I., Morrow M., Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. Journal of Clinical Oncology 2005 23 13 3001 3007 2-s2.0-21144443359 10.1200/JCO.2005.04.028